Evidence map›Paper›PMID 36791265›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2023

Immune cell counts in cerebrospinal fluid predict cognitive function in aging and neurodegenerative disease.

Allison Snyder, Harli Grant, Austin Chou, Cutter A Lindbergh, Joel H Kramer, Bruce L Miller, Fanny M Elahi

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. An ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Allison SnyderNational Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
Harli GrantMemory and Aging Center, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Austin ChouBrain and Spinal Injury Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Cutter A LindberghDepartment of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Joel H KramerMemory and Aging Center, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Bruce L MillerMemory and Aging Center, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
Fanny M ElahiMemory and Aging Center, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
University Memory and Aging Center · USUniversity of California, San Francisco · USNational Institute of Neurological Disorders and Stroke · USUniversity of Connecticut · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Gil Dan Rabinovici · 2019 to 2026
$36.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
Mechanisms of Executive Decline in Normal AgingR01AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaitlin B Casaletto, JOEL H KRAMER · 2009 to 2026
$8.3M
Multidisciplinary Research Fellowship in Alzheimer’s disease and Related DementiasT32AG023481 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE L MILLER, HOWARD J ROSEN · 2005 to 2026
$7.4M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Biological Predictors Of Brain Aging Trajectories Diversity Supplement: African American Outreach And The Intersection Between Social Determinants Of Health And Biomarkers Of Degenerative DiseaseRF1AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2020 to 2021
$5.3M
A Precision Medicine Approach To Study Targetable Pathways in Vascular DementiaIK2CX002180 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI ELAHI, FANNY M · 2021 to 2024
–
CSRD VA IK2 CX002180NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG062422NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG032289NIA NIH HHS R01 AG057234NIA NIH HHS RF1 AG032289NIA NIH HHS T32 AG023481
6 · The paper itself

Abstract

introductionImmune dysfunction is important in aging and neurodegeneration; lacking clinically available tools limits research translation. We tested associations of cerebral spinal fluid (CSF) monocyte-to-lymphocyte ratio (MLR)-innate immune activation surrogate-with cognition in an aging and dementia cohort, hypothesizing that elevated MLR is associated with poorer executive functioning.

methodsCSF MLR was calculated in well-characterized, genotyped participants enrolled in studies of aging and dementia at University of California, San Francisco Memory and Aging Center (n = 199, mean age 57.5 years, SD 11.9). Linear models tested associations with episodic memory and executive function (verbal fluency, speeded set-shifting).

resultsAging was associated with higher CSF monocyte, lower lymphocyte counts, and higher MLRs (p < 0.001). MLR was associated with verbal fluency (p < 0.05) only. DISCUSSION: Using clinical labs, we show an inverse association between CSF MLR and executive function in aging and dementia, supporting the utility of clinical labs in capturing associations between innate immune dysfunction and neurodegeneration.

Indexed as

Alzheimer DiseaseCognitive DysfunctionNeurodegenerative DiseasesAgingAmyloid beta-PeptidesBiomarkersCell CountCognitionHumansMiddle AgedAmyloid beta-PeptidesBiomarkersagingcerebrospinal fluidcognitionexecutive functioninflammationneurodegeneration

Identifiers

PMID36791265
PMCPMC10425564
OpenAlexW4320896026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.